CIK 0001781174 · <br>Emerging growth company
Acrivon Therapeutics, Inc.
Sign in to watch- Ticker
- ACRV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 825125532
- Phone
- 617-207-8979
- Business address
- 480 ARSENAL WAY, SUITE 100, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $38,534
- in 8 filings
Net −$38,534. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Blume-Jensen Peter −$34K President and CEO sold <1% of stake
- Miller Mary −$2K Chief Legal Officer sold 1% of stake
- Devroe Eric −$1K Chief Operating Officer sold <1% of stake
- Gamelin Erick −$804 Chief Development Officer sold <1% of stake
- Peterson Katharine −$203 Chief Accounting Officer sold <1% of stake
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-14 | Blume-Jensen Peter President and CEO | Purchase | +49,000 | $1.68 | $82K | 2,095,771 |
| 2026-01-14 | Levy Adam D. Chief Financial Officer | Purchase | +8,832 | $1.70 | $15K | 20,983 |
| 2026-01-13 | Devroe Eric Chief Operating Officer | Purchase | +10,000 | $1.72 | $17K | 75,308 |
| 2025-11-21 | Blume-Jensen Peter President and CEO | Shares withheld for taxes | −19,904 | $2.30 | $46K | 2,046,771 |
| 2025-11-14 | Peterson Katharine Chief Accounting Officer | Shares withheld for taxes | −99 | $2.24 | $222 | 4,122 |
| 2025-11-14 | Miller Mary Chief Legal Officer | Shares withheld for taxes | −184 | $2.24 | $412 | 34,555 |
| 2025-11-14 | Gamelin Erick Chief Development Officer | Shares withheld for taxes | −403 | $2.24 | $903 | 15,283 |
| 2025-11-14 | Devroe Eric Chief Operating Officer | Shares withheld for taxes | −613 | $2.24 | $1K | 65,308 |
| 2025-11-14 | Blume-Jensen Peter President and CEO | Shares withheld for taxes | −59,765 | $2.24 | $134K | 2,066,675 |
| 2025-11-14 | Blume-Jensen Peter President and CEO | Shares withheld for taxes | −490 | $2.24 | $1K | 314,706 |
| 2025-10-17 | Miller Mary Chief Legal Officer | Shares withheld for taxes | −558 | $1.81 | $1K | 34,739 |
| 2025-10-01 | Mirza Mansoor Raza Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +225,000 | 225,000 | ||
| 2025-10-01 | Miller Mary Chief Legal Officer | Shares withheld for taxes | −284 | $1.81 | $514 | 35,297 |
| 2025-08-21 | Blume-Jensen Peter President and CEO | Shares withheld for taxes | −19,905 | $1.32 | $26K | 2,126,440 |
| 2025-08-14 | Peterson Katharine Chief Accounting Officer | Shares withheld for taxes | −99 | $1.39 | $138 | 4,221 |
| 2025-08-14 | Miller Mary Chief Legal Officer | Shares withheld for taxes | −184 | $1.39 | $256 | 35,581 |
| 2025-08-14 | Gamelin Erick Chief Development Officer | Shares withheld for taxes | −403 | $1.39 | $560 | 15,686 |
| 2025-08-14 | Devroe Eric Chief Operating Officer | Shares withheld for taxes | −613 | $1.39 | $852 | 65,921 |
| 2025-08-14 | Blume-Jensen Peter President and CEO | Shares withheld for taxes | −59,766 | $1.39 | $83K | 2,146,345 |
| 2025-08-14 | Blume-Jensen Peter President and CEO | Shares withheld for taxes | −490 | $1.39 | $681 | 315,196 |
Page 4 of 6 · 113 trades